Purchase Order 75D30123P17809
Award Date 8/29/23
Potential Completion Date 9/30/23
Potential Value $31K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Rodeo, CA 94547, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $7,006.40 firm fixed price purchase order to Bio-Rad Laboratories, Inc. Life Science Group Division for a BIO-RAD THERMAL CYCLER. As the prime contractor, Bio-Rad Laboratories will deliver the requested thermal cycler equipment to support laboratory programs at the CDC location. No subcontractors or additional context was provided regarding the equipment's intended use. The single...
- The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $8,771.15 firm fixed-price purchase order to Bio-Rad Laboratories, Inc. Life Science Group Division for BIORAD GENE PULSAR CALVET. As the prime contractor, Bio-Rad Laboratories will deliver the requested products from its Fort Collins, Colorado location by August 30, 2023 in support of the CDC's disease prevention and control efforts. No subcontractors or set aside designations were...
- The Centers for Disease Control and Prevention, located in Pittsburgh, awarded a $7,000 purchase order to Bio-Rad Laboratories, Inc. for a T100 Thermal Cycler System. As the prime contractor, Bio-Rad will deliver the requested thermal cycler to CDC under a firm fixed price contract running from September 1st through October 3rd, 2023. The parent company of Bio-Rad Laboratories, Inc. is Bio-Rad Laboratories, Inc., headquartered in Hercules, California. No additional subcontractors or set aside...
- The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $28,637.70 firm fixed price purchase order to Bio-Rad Laboratories, Inc. Life Science Group Division for CFX OPUS 96 under contract number CFX OPUS 96. As the prime contractor, Bio-Rad Laboratories will deliver their CFX OPUS 96 product to the CDC location in Hercules, California. Performance is required between September 21-30, 2023. No subcontractors or set aside designations were...
- Bio-Rad Laboratories Inc. was awarded a $33,000 firm fixed-price purchase order by the Centers for Disease Control and Prevention (CDC) Pittsburgh on August 14, 2024, for FDA-approved test kits, readers, and laptops designed to strengthen rapid test quality assurance internationally. The contract, which carries an ultimate completion date of April 22, 2025, represents an unrestricted procurement with no small business set-aside designation. Performance will be executed at Bio-Rad's Hercules,...
- The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $48,611.50 firm fixed price purchase order to Bio-Rad Laboratories, Inc. Diagnostics Division for the delivery of BIO-PLEX 200 ARRAY READER equipment. As the prime contractor, Bio-Rad Laboratories will provide the requested products to CDC under the terms of this contract, which runs from July 18, 2023 through August 31, 2023. The place of performance is Bio-Rad Laboratories' facility in...
- Bio-Rad Laboratories, Inc. was awarded a $27,255.81 firm fixed price purchase order by the Department of Health and Human Services Centers for Disease Control and Prevention for the purchase of a digital PCR maintenance agreement. The place of performance is Bio-Rad's Hercules, California location. No set-aside designation was used for this award. Bio-Rad is a leading life sciences supplier that holds a $1 billion blanket purchase agreement with HHS's National Institutes of Health through 2024...
- Bio-Rad Laboratories, Inc. was awarded a firm fixed-price purchase order valued at $52,451.52 by the Centers for Disease Control and Prevention (CDC) Pittsburgh facility, with performance executed at the company's manufacturing facility in Hercules, California. The contract was awarded on September 3, 2021, with an ultimate completion date of September 2, 2024. No small business set-aside designation was applied to this award, consistent with Bio-Rad's status as an established large federal...
- The Centers for Disease Control and Prevention (CDC) awarded a $78,000 purchase order to Bio-Rad Laboratories, Inc. for the delivery of Bio-Rad Bio-Plex 200 systems. As the prime contractor, Bio-Rad Laboratories will provide the requested instrumentation from its Life Science Group Division. Performance will take place in Hercules, California over a period of one month, from September 12 to October 11, 2023. This firm fixed price contract supports the CDC's disease prevention and public health...
- This federal contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Bio-Rad Laboratories, Inc. Life Science Group Division, a for-profit manufacturer of biotechnology products and laboratory equipment. The $103,398.60 firm-fixed-price purchase order is for the delivery of a DDPCR SYSTEM. No set-aside designation was indicated. Bio-Rad Laboratories holds a 5-year, $1 billion blanket purchase agreement with the National Institutes of...
The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $30,642 fixed-price purchase order to Bio-Rad Laboratories, Inc. for PCR systems. As the prime contractor, Bio-Rad will deliver its Life Science Group Division's PCR systems to support HHS-CDC programs. The place of performance is Bio-Rad's headquarters in Hercules, California. The period of performance is from August 29, 2023 through September 30, 2023. No subcontractors or set aside designations were identified. This purchase augments HHS-CDC's disease prevention and public health efforts through acquisition of PCR technology for detection of pathogens.
Generated 12/19/23, 8:48 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $30.6k | 8/29/23 |